CytoMed Therapeutics Limited Interest Expense
CytoMed Therapeutics Limited (GDTC) reported Interest Expense of SGD 20.91 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpense · last filed 2026-03-31
SGD
| Period end | Interest Expense 12 month |
|---|---|
| 2025-12-31 | 20.91K SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 20.31K SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 51.28K SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 125.17K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 117.70K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 105.52K SGD 20-F · filed 2023-05-01 |
USD
| Period end | Interest Expense 12 month |
|---|---|
| 2025-12-31 | $16.26K 20-F · filed 2026-03-31 |
| 2024-12-31 | $14.87K 20-F · filed 2025-04-28 |
| 2023-12-31 | $38.87K 20-F · filed 2024-04-22 |
| 2022-12-31 | $93.39K 20-F · filed 2023-05-01 |